Mayzent and Multiple sclerosis - a phase IV clinical study of FDA data
Multiple sclerosis is found among people who take Mayzent, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Mayzent and have Multiple sclerosis. It is created by eHealthMe based on reports of 7,239 people who have side effects when taking Mayzent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,239 people reported to have side effects when taking Mayzent.
Among them, 308 people (4.25%) have Multiple sclerosis.
What is Mayzent?
Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 7,240 Mayzent users for its effectiveness, alternative drugs and more.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,990 drugs and 1,266 conditions by eHealthMe.
Number of Mayzent and Multiple sclerosis reports submitted per year:
Time on Mayzent when people have Multiple sclerosis *:
Gender of people who have Multiple sclerosis when taking Mayzent*:
Age of people who have Multiple sclerosis when taking Mayzent *:
Common drugs people take besides Mayzent *:
Common side effects people have besides Multiple sclerosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Mayzent and have Multiple sclerosis?Check whether Multiple sclerosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
How severe was Multiple sclerosis and when was it recovered:
Expand to all the drugs that have ingredients of siponimod fumaric acid:
Alternative drugs to, pros and cons of Mayzent:
- Mayzent (7,240 reports)
Common Mayzent side effects:
Browse all side effects of Mayzent:a b c d e f g h i j k l m n o p q r s t u v w x y z
Multiple sclerosis treatments and more:
- Multiple sclerosis (690,386 reports)
COVID vaccines that are related to Multiple sclerosis:
- Multiple sclerosis in Moderna COVID Vaccine
- Multiple sclerosis in Pfizer BioNTech Covid Vaccine
- Multiple sclerosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Multiple sclerosis:
All the drugs that are associated with Multiple sclerosis:
- Multiple sclerosis (1,990 drugs)
Common conditions associated with Multiple sclerosis:
All the conditions that are associated with Multiple sclerosis:
- Multiple sclerosis (1,266 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on siponimod fumaric acid (the active ingredients of Mayzent) and Mayzent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Celestone and Wound - 5 seconds ago
- Androderm and Back Pain Aggravated - 12 seconds ago
- Multivitamin and Inner Ear Disorder - 17 seconds ago
- Travatan and Joint Injury - 18 seconds ago
- Night Sweats and drugs of ingredients of paroxetine hydrochloride - 20 seconds ago
- Eligard and Vitamin B6 drug interaction - 22 seconds ago
- Lanoxin and Gums - Swollen - 23 seconds ago
- Vimpat and Fenofibrate drug interaction - 32 seconds ago
- Abilify and Xanax Xr drug interaction - 35 seconds ago
- Metformin and Vein Disorder - 38 seconds ago